RSSTrial Methodology

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

Therapeutic Potential of Ponesimod Alone and in Combination with Dimethyl Fumarate in Experimental Models of Multiple Sclerosis

| March 1, 2019

by Laetitia Pouzol, MSc, PharmD; Luca Piali, PhD; Claude CA Bernard, PhD; Marianne M. Martinic, PhD; Beat Steiner, PhD; and Martine Clozel, MD Drs. Pouzol and Clozel were with Actelion Pharmaceuticals Ltd. in Allschwil, Switzerland, at the time of this research, and are presently with Idorsia Pharmaceuticals Ltd. in Allschwil, Switzerland. Dr. Piali was with […]

Continue Reading

CNS Summit 2018 Abstracts of Poster Presentations

CNS Summit 2018 Abstracts of Poster Presentations

| November 1, 2018

A message from the editor: Dear Colleagues: Welcome to the annual CNS Summit Abstracts of Poster Presentations supplement to Innovations in Clinical Neuroscience. We are pleased to provide you with this reference guide to some of the innovative research that is being presented during CNS Summit 2018. The supplement is also available online by visiting […]

Continue Reading

Measurement-based Care in Psychiatry— Past, Present, and Future

Measurement-based Care in Psychiatry— Past, Present, and Future

| November 1, 2018

by Ahmed Aboraya, MD, Dr.PH; Henry A. Nasrallah, MD; Daniel E. Elswick, MD; Ahmed Elshazly, MD; Nevine Estephan, MD; Dalia Aboraya, BA; Seher Berzingi; Josleen Chumbers; Aara Berzingi, BA; John Justice, MD; Jawad Zafar, DO; and Sheena Dohar, MD Dr. Aboraya is Chief of Psychiatry at William R. Sharpe, Jr. Hospital, Clinical Professor of Psychiatry […]

Continue Reading

Validation of an Equation Model to Predict Intracranial Pressure in Clinical Studies

Validation of an Equation Model to Predict Intracranial Pressure in Clinical Studies

| November 1, 2018

by Niro Kasahara, MD; Mateus L. Matuoka, MD; Katia S. Santos, MD; Natasha F.S. Cruz, MD; Alvaro R. Martins, MD; and Stanley Nigro, MD Drs. Kasahara, Matuoka, Santos, and Cruz are with the Department of Ophthalmology, Irmandade da Santa Casa de Misericordia de Sao Paulo in Sao Paulo, Brazil. Dr. Kasahara is also with Santa […]

Continue Reading

The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review

The Assessment and Measurement of Wellness in the Clinical Medical Setting: A Systematic Review

| October 1, 2018

by Ryan Bart, DO; Waguih William IsHak, MD, FAPA; Shaina Ganjian, MS; Karim Yahia Jaffer; Marina Abdelmesseh, MD, CIC; Sophia Hanna, BA; Yasmine Gohar, BA; Gezelle Azar, Bs; Brigitte Vanle, PhD; Jonathan Dang, MD; and Itai Danovitch, MD Dr. Bart is with Western University of Health Sciences and Cedars-Sinai Medical Center, in Los Angeles, California. […]

Continue Reading

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

| July 1, 2018 | 0 Comments

By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and Dr. Vannappagari is with Epidemiology and Real World Evidence at ViiV Healthcare in Research Triangle Park, North Carolina. Ms. Whillis was with GlaxoSmithKline, plc, in […]

Continue Reading

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

Letter to the Editor: Can YouTube® Disseminate Dementia Knowledge to Sinagpore Chinese?

| July 1, 2018 | 0 Comments

By Benjamin K.P. Woo, MD Funding/financial disclosures: The authors have no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: A community-based epidemiological survey has suggested that the prevalence of cognitive impairment and dementia is approximately 15.2 percent in Singapore Chinese.[1] While early […]

Continue Reading

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

Development of a Behavioral Health Stigma Measure and Application of Machine Learning for Classification

| May 1, 2018 | 0 Comments

By Farah Tokmic, PhD; Mirsad Hadzikadic, PhD; James R. Cook, PhD; and Oleg V. Tcheremissine, MD Drs. Tokmic and Hadzikadic are with the Department of Software & Information Systems at the University of North Carolina, in Charlotte, North Carolina. Dr. Cook is with the Department of Psychology at the University of North Carolina, in Charlotte, […]

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

| May 1, 2018 | 0 Comments

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading